Arrowhead Pharmaceuticals, Inc. (ARWR) stock
ARWRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-K on Nov 12, 2026Score 5/3035% above fair value
$43.11+0.12 (+0.28%)
Close on Nov 18, 2026Market cap $6.09BP/E –Yield –
Arrowhead Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Arrowhead Pharmaceuticals's price to book ratio was 15.0× on Nov 11, 2026, against 15.3× a year earlier. Over the last 5 years it ranged from 3.2× to 45.2×, with a median of 12.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 15.0× | −4.4 |
| 2025 | Dec 31, 2025 | 19.3× | +6.7 |
| 2024 | Dec 31, 2024 | 12.6× | +0.5 |
| 2023 | Dec 29, 2023 | 12.1× | +1.3 |
| 2022 | Dec 30, 2022 | 10.8× | −6.1 |
| 2021 | Dec 31, 2021 | 16.9× | −0.1 |
| 2020 | Dec 31, 2020 | 17.0× | −7.8 |
| 2019 | Dec 31, 2019 | 24.8× | +13.3 |
| 2018 | Dec 31, 2018 | 11.5× | +8.1 |
| 2017 | Dec 29, 2017 | 3.4× | +2.2 |
| 2016 | Dec 30, 2016 | 1.1× | −2.2 |
| 2015 | Dec 31, 2015 | 3.3× | +0.9 |
| 2014 | Dec 31, 2014 | 2.4× | −10.4 |
| 2013 | Dec 31, 2013 | 12.8× | +9.9 |
| 2012 | Dec 31, 2012 | 2.9× | +0.1 |
| 2011 | Dec 30, 2011 | 2.8× | −4.3 |
| 2010 | Dec 31, 2010 | 7.1× | – |
See a number that looks wrong?